{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T04:02:58Z","timestamp":1745726578959,"version":"3.40.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA046234"],"award-info":[{"award-number":["K01DA046234"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10461-025-04615-z","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T09:43:57Z","timestamp":1737366237000},"page":"1449-1457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Estimating the Cost-Saving Threshold of a Rural Syringe Services Program Before and During the COVID-19 Pandemic"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0540-3824","authenticated-orcid":false,"given":"Sean T.","family":"Allen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian W.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin E.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"O\u2019Rourke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Hazelett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Kilkenny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Latkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"4615_CR1","unstructured":"CDC. Syringe Services Programs (SSPs). Available from: https:\/\/www.cdc.gov\/ssp\/index.html"},{"key":"4615_CR2","unstructured":"Association AM. Needle & Syringe Exchanges. 2023. Available from: https:\/\/www.ama-assn.org\/topics\/needle-syringe-exchanges"},{"issue":"48","key":"4615_CR3","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","volume":"64","author":"DC Des Jarlais","year":"2015","unstructured":"Des Jarlais DC, et al. Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and rural areas - United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(48):1337\u201341.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"4615_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","volume":"17","author":"RM Fernandes","year":"2017","unstructured":"Fernandes RM, et al. Effectiveness of needle and syringe programmes in people who inject drugs - an overview of systematic reviews. BMC Public Health. 2017;17(1):309.","journal-title":"BMC Public Health"},{"key":"4615_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugpo.2019.04.006","volume":"70","author":"CM Jones","year":"2019","unstructured":"Jones CM. Syringe services programs: an examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S. Int J Drug Policy. 2019;70:22\u201332.","journal-title":"Int J Drug Policy"},{"key":"4615_CR6","unstructured":"CDC. HIV and Substance Use. Available from: https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/cdc-hiv-substanceuse.pdf"},{"key":"4615_CR7","unstructured":"CDC. Diagnoses of HIV Infection in the United States and Dependent Areas, 2018: Persons Who Inject Drugs. 2020. Available from: https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance-report-2018-updated-vol-31.pdf"},{"key":"4615_CR8","unstructured":"CDC. 2022. Available from: https:\/\/www.cdc.gov\/hiv\/group\/hiv-idu.html"},{"issue":"Supplement5","key":"4615_CR9","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1093\/infdis\/jiaa432","volume":"222","author":"A Levitt","year":"2020","unstructured":"Levitt A, et al. Infectious diseases and Injection Drug Use: Public Health Burden and Response. J Infect Dis. 2020;222(Supplement5):S213\u20137.","journal-title":"J Infect Dis"},{"issue":"2","key":"4615_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1001\/jama.1994.03510260047027","volume":"271","author":"JK Watters","year":"1994","unstructured":"Watters JK, et al. Syringe and needle exchange as HIV\/AIDS prevention for injection drug users. JAMA. 1994;271(2):115\u201320.","journal-title":"JAMA"},{"issue":"Suppl 2","key":"4615_CR11","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1097\/QAI.0000000000002176","volume":"82","author":"MS Ruiz","year":"2019","unstructured":"Ruiz MS, et al. Using interrupted Time Series Analysis to measure the impact of Legalized Syringe Exchange on HIV diagnoses in Baltimore and Philadelphia. J Acquir Immune Defic Syndr. 2019;82(Suppl 2):S148\u201354.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"4615_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10461-015-1143-6","volume":"20","author":"MS Ruiz","year":"2016","unstructured":"Ruiz MS, O\u2019Rourke A, Allen ST. Impact evaluation of a policy intervention for HIV Prevention in Washington, DC. AIDS Behav. 2016;20(1):22\u20138.","journal-title":"AIDS Behav"},{"issue":"11","key":"4615_CR13","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1007\/s10461-014-0789-9","volume":"18","author":"TQ Nguyen","year":"2014","unstructured":"Nguyen TQ, et al. Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment. AIDS Behav. 2014;18(11):2144\u201355.","journal-title":"AIDS Behav"},{"key":"4615_CR14","unstructured":"CDC. Summary of Information on The Safety and Effectiveness of Syringe Services Programs (SSPs). 2021. Available from: https:\/\/www.cdc.gov\/ssp\/syringe-services-programs-summary.html"},{"issue":"2","key":"4615_CR15","first-page":"137","volume":"27","author":"SC Ijioma","year":"2021","unstructured":"Ijioma SC, et al. Cost-effectiveness of syringe service programs, medications for opioid use disorder, and combination programs in hepatitis C harm reduction among opioid injection drug users: a public payer perspective using a decision tree. J Manag Care Spec Pharm. 2021;27(2):137\u201346.","journal-title":"J Manag Care Spec Pharm"},{"issue":"9","key":"4615_CR16","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/j.1360-0443.2008.02465.x","volume":"104","author":"DC Des Jarlais","year":"2009","unstructured":"Des Jarlais DC, et al. Doing harm reduction better: syringe exchange in the United States. Addiction. 2009;104(9):1441\u20136.","journal-title":"Addiction"},{"key":"4615_CR17","doi-asserted-by":"crossref","unstructured":"Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS, 2001. 15(11).","DOI":"10.1097\/00002030-200107270-00002"},{"issue":"9","key":"4615_CR18","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1007\/s10461-013-0593-y","volume":"17","author":"AS Abdul-Quader","year":"2013","unstructured":"Abdul-Quader AS, et al. Effectiveness of structural-level needle\/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav. 2013;17(9):2878\u201392.","journal-title":"AIDS Behav"},{"issue":"1","key":"4615_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ije\/dyt243","volume":"43","author":"EJ Aspinall","year":"2014","unstructured":"Aspinall EJ, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):235\u201348.","journal-title":"Int J Epidemiol"},{"key":"4615_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.drugalcdep.2018.03.049","volume":"188","author":"CE Paquette","year":"2018","unstructured":"Paquette CE, Pollini RA. Injection drug use, HIV\/HCV, and related services in nonurban areas of the United States: a systematic review. Drug Alcohol Depend. 2018;188:239\u201350.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"4615_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/QAI.0000000000001098","volume":"73","author":"MM Van Handel","year":"2016","unstructured":"Van Handel MM, et al. County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr. 2016;73(3):323\u201331.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"16","key":"4615_CR22","first-page":"443","volume":"64","author":"C Conrad","year":"2015","unstructured":"Conrad C, et al. Community Outbreak of HIV infection linked to Injection Drug Use of Oxymorphone\u2013Indiana, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(16):443\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"4615_CR23","first-page":"90","volume":"24","author":"DM Janowicz","year":"2016","unstructured":"Janowicz DM. HIV Transmission and Injection Drug Use: lessons from the Indiana outbreak. Top Antivir Med. 2016;24(2):90\u20132.","journal-title":"Top Antivir Med"},{"issue":"Suppl 5","key":"4615_CR24","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.1093\/infdis\/jiaa112","volume":"222","author":"SB Lyss","year":"2020","unstructured":"Lyss SB, et al. Responding to outbreaks of human immunodeficiency Virus among persons who inject drugs-United States, 2016\u20132019: perspectives on recent experience and lessons learned. J Infect Dis. 2020;222(Suppl 5):S239\u201349.","journal-title":"J Infect Dis"},{"issue":"3","key":"4615_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa1515195","volume":"375","author":"PJ Peters","year":"2016","unstructured":"Peters PJ, et al. HIV infection linked to Injection Use of Oxymorphone in Indiana, 2014\u20132015. N Engl J Med. 2016;375(3):229\u201339.","journal-title":"N Engl J Med"},{"issue":"1","key":"4615_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1080\/07853890.2022.2028001","volume":"54","author":"ST Allen","year":"2022","unstructured":"Allen ST, et al. Applications of research evidence during processes to acquire approvals for syringe services program implementation in rural counties in Kentucky. Ann Med. 2022;54(1):404\u201312.","journal-title":"Ann Med"},{"key":"4615_CR27","unstructured":"Kentucky Cabinet for Health and Family Services. Syringe Exchange Programs. Available from: https:\/\/chfs.ky.gov\/agencies\/dph\/dehp\/hab\/Pages\/kyseps.aspx"},{"issue":"1","key":"4615_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/jrh.12698","volume":"39","author":"DM Carpenter","year":"2023","unstructured":"Carpenter DM, et al. Factors associated with perceived ease of access to syringes in Appalachian North Carolina. J Rural Health. 2023;39(1):212\u201322.","journal-title":"J Rural Health"},{"issue":"3","key":"4615_CR29","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/cid\/cix333","volume":"65","author":"L Canary","year":"2017","unstructured":"Canary L, et al. Geographic Disparities in Access to Syringe Services Programs among Young Persons with Hepatitis C Virus Infection in the United States. Clin Infect Dis. 2017;65(3):514\u20137.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4615_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12954-021-00524-1","volume":"18","author":"K Thakarar","year":"2021","unstructured":"Thakarar K, et al. Injections and infections: understanding syringe service program utilization in a rural state. Harm Reduct J. 2021;18(1):74.","journal-title":"Harm Reduct J"},{"issue":"2","key":"4615_CR31","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/00220426221108694","volume":"53","author":"HDG Montaque","year":"2023","unstructured":"Montaque HDG, et al. Mechanisms for expanding harm reduction for opioid use in Suburban and Rural U.S. settings. J Drug Issues. 2023;53(2):196\u2013212.","journal-title":"J Drug Issues"},{"issue":"1","key":"4615_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/add.15113","volume":"116","author":"RA Pollini","year":"2021","unstructured":"Pollini RA, et al. It\u2019s just basically a box full of disease\u2019-navigating sterile syringe scarcity in a rural New England state. Addiction. 2021;116(1):107\u201315.","journal-title":"Addiction"},{"issue":"13","key":"4615_CR33","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1080\/10826084.2021.1958863","volume":"56","author":"NA Carnes","year":"2021","unstructured":"Carnes NA, et al. Access to HIV, viral Hepatitis, and Substance Use Disorder Treatment\/Overdose Prevention Services: a Qualitative Analysis of Syringe Service Programs (SSPs) serving rural PWID. Subst Use Misuse. 2021;56(13):1933\u201340.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"4615_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12954-021-00518-z","volume":"18","author":"U Ibragimov","year":"2021","unstructured":"Ibragimov U, et al. Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky. Harm Reduct J. 2021;18(1):68.","journal-title":"Harm Reduct J"},{"issue":"1","key":"4615_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12954-019-0305-7","volume":"16","author":"ST Allen","year":"2019","unstructured":"Allen ST, et al. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs. Harm Reduct J. 2019;16(1):33.","journal-title":"Harm Reduct J"},{"issue":"5","key":"4615_CR36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/phr\/114.5.439","volume":"114","author":"RS Broadhead","year":"1999","unstructured":"Broadhead RS, van Hulst Y, Heckathorn DD. The impact of a needle exchange\u2019s closure. Public Health Rep. 1999;114(5):439\u201347.","journal-title":"Public Health Rep"},{"key":"4615_CR37","doi-asserted-by":"crossref","unstructured":"Zang X et al. The impact of syringe services program closure on the risk of rebound HIV outbreaks among people who inject drugs: a modeling study. Aids, 2022.","DOI":"10.2139\/ssrn.3778009"},{"issue":"1","key":"4615_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12954-021-00568-3","volume":"18","author":"Y Aponte-Melendez","year":"2021","unstructured":"Aponte-Melendez Y, et al. The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services. Harm Reduct J. 2021;18(1):118.","journal-title":"Harm Reduct J"},{"key":"4615_CR39","doi-asserted-by":"publisher","first-page":"102821","DOI":"10.1016\/j.drugpo.2020.102821","volume":"83","author":"TS Bartholomew","year":"2020","unstructured":"Bartholomew TS, et al. Syringe services program (SSP) operational changes during the COVID-19 global outbreak. Int J Drug Policy. 2020;83:102821.","journal-title":"Int J Drug Policy"},{"key":"4615_CR40","doi-asserted-by":"publisher","first-page":"103889","DOI":"10.1016\/j.drugpo.2022.103889","volume":"110","author":"H Bradley","year":"2022","unstructured":"Bradley H, et al. A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic. Int J Drug Policy. 2022;110:103889.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"4615_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10461-021-03332-7","volume":"26","author":"MC Frost","year":"2022","unstructured":"Frost MC, et al. Program adaptations to provide harm reduction services during the COVID-19 pandemic: a Qualitative Study of Syringe Services Programs in the U. S AIDS Behav. 2022;26(1):57\u201368.","journal-title":"S AIDS Behav"},{"issue":"1","key":"4615_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12954-022-00631-7","volume":"19","author":"JL Glick","year":"2022","unstructured":"Glick JL, et al. Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky. Harm Reduct J. 2022;19(1):47.","journal-title":"Harm Reduct J"},{"key":"4615_CR43","doi-asserted-by":"publisher","first-page":"109323","DOI":"10.1016\/j.drugalcdep.2022.109323","volume":"232","author":"CN Behrends","year":"2022","unstructured":"Behrends CN, et al. Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020. Drug Alcohol Depend. 2022;232:109323.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"4615_CR44","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1007\/s10461-020-02886-2","volume":"24","author":"SN Glick","year":"2020","unstructured":"Glick SN, et al. The impact of COVID-19 on Syringe Services Programs in the United States. AIDS Behav. 2020;24(9):2466\u20138.","journal-title":"AIDS Behav"},{"issue":"3","key":"4615_CR45","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2105\/AJPH.2018.304873","volume":"109","author":"ST Allen","year":"2019","unstructured":"Allen ST, et al. Estimating the number of people who inject drugs in a Rural County in Appalachia. Am J Public Health. 2019;109(3):445\u201350.","journal-title":"Am J Public Health"},{"key":"4615_CR46","unstructured":"Bureau USC. QuickFacts Cabell County, West Virginia. 2021 [cited 2023 11-15-23]; Available from: https:\/\/www.census.gov\/quickfacts\/cabellcountywestvirginia"},{"key":"4615_CR47","unstructured":"West Virginia Bureau for Public Health. Outbreak of Human Immunodeficiency Virus (HIV) Linked to Injection Drug Use. 2022. Available from: https:\/\/oeps.wv.gov\/hiv-aids\/Pages\/default.aspx"},{"key":"4615_CR48","unstructured":"NYC Health. HIV\/AIDS Annual Surveillance Statistics. 2021. Available from: https:\/\/www.nyc.gov\/site\/doh\/data\/data-sets\/hiv-aids-annual-surveillance-statistics.page"},{"key":"4615_CR49","unstructured":"Baltimore City Health Department. HIV\/STD Data & Resources. 2021. Available from: https:\/\/health.baltimorecity.gov\/hivstd-data-resources"},{"key":"4615_CR50","unstructured":"Georgia Department of Public Health.Georgia HIV Surveillance Data. Available from: https:\/\/dph.georgia.gov\/epidemiology\/georgias-hivaids-epidemiology-section\/georgia-hiv-surveillance-data"},{"key":"4615_CR51","unstructured":"Chicago Department of Public Health. HIV\u2009+\u2009STI DATA REPORT. 2022. Available from: https:\/\/www.chicago.gov\/content\/dam\/city\/depts\/cdph\/HIV_STI\/CDPH_HIVSTI_DataReport_09-2022.pdf"},{"key":"4615_CR52","unstructured":"Florida Department of Health. Human Immunodeficiency Virus (HIV) Diagnoses. 2022. Available from: https:\/\/www.flhealthcharts.gov\/ChartsReports\/rdPage.aspx?rdReport=HIVAIDS.DataViewer&cid=471"},{"issue":"16","key":"4615_CR53","doi-asserted-by":"publisher","first-page":"499","DOI":"10.15585\/mmwr.mm6916a2","volume":"69","author":"A Atkins","year":"2020","unstructured":"Atkins A, et al. Notes from the field: outbreak of human immunodeficiency virus infection among persons who inject drugs - Cabell County, West Virginia, 2018\u20132019. MMWR Morb Mortal Wkly Rep. 2020;69(16):499\u2013500.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"4615_CR54","doi-asserted-by":"publisher","first-page":"66","DOI":"10.15585\/mmwr.mm7102a4","volume":"71","author":"RB Hershow","year":"2022","unstructured":"Hershow RB, et al. Notes from the field: HIV Outbreak during the COVID-19 pandemic among persons who inject drugs - Kanawha County, West Virginia, 2019\u20132021. MMWR Morb Mortal Wkly Rep. 2022;71(2):66\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"4615_CR55","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/infdis\/jix307","volume":"216","author":"EM Campbell","year":"2017","unstructured":"Campbell EM, et al. Detailed Transmission Network Analysis of a large opiate-driven outbreak of HIV infection in the United States. J Infect Dis. 2017;216(9):1053\u201362.","journal-title":"J Infect Dis"},{"issue":"5 Suppl 1","key":"4615_CR56","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1016\/j.amepre.2021.05.039","volume":"61","author":"RP McClung","year":"2021","unstructured":"McClung RP, et al. Response to a large HIV outbreak, Cabell County, West Virginia, 2018\u20132019. Am J Prev Med. 2021;61(5 Suppl 1):S143\u201350.","journal-title":"Am J Prev Med"},{"key":"4615_CR57","doi-asserted-by":"publisher","first-page":"103176","DOI":"10.1016\/j.drugpo.2021.103176","volume":"93","author":"ST Allen","year":"2021","unstructured":"Allen ST, et al. Engagement in drug treatment following nonfatal overdose among people who inject drugs in Appalachia. Int J Drug Policy. 2021;93:103176.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"4615_CR58","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/add.15151","volume":"116","author":"RH White","year":"2021","unstructured":"White RH, et al. Prevalence and correlates of receptive syringe-sharing among people who inject drugs in rural Appalachia. Addiction. 2021;116(2):328\u201336.","journal-title":"Addiction"},{"issue":"6","key":"4615_CR59","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1007\/s10461-019-02767-3","volume":"24","author":"ST Allen","year":"2020","unstructured":"Allen ST, et al. Barriers and facilitators to PrEP Use among people who inject drugs in rural Appalachia: a qualitative study. AIDS Behav. 2020;24(6):1942\u201350.","journal-title":"AIDS Behav"},{"issue":"1","key":"4615_CR60","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/0033354921994202","volume":"137","author":"NW Furukawa","year":"2022","unstructured":"Furukawa NW, et al. Expansion of Preexposure Prophylaxis Capacity in response to an HIV Outbreak among people who inject drugs-Cabell County, West Virginia, 2019. Public Health Rep. 2022;137(1):25\u201331.","journal-title":"Public Health Rep"},{"issue":"10","key":"4615_CR61","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s40273-020-00942-2","volume":"38","author":"DD Kim","year":"2020","unstructured":"Kim DD, et al. Perspective and costing in cost-effectiveness analysis, 1974\u20132018. PharmacoEconomics. 2020;38(10):1135\u201345.","journal-title":"PharmacoEconomics"},{"key":"4615_CR62","unstructured":"NIH. Indirect Cost: Definition and Example. 2020. Available from: https:\/\/oamp.od.nih.gov\/division-of-financial-advisory-services\/indirect-cost-branch\/indirect-cost-submission\/indirect-cost-definition-and-example"},{"key":"4615_CR63","unstructured":"US Bureau of Labor Statistics. CPI Inflation Calculator. Available from: https:\/\/www.bls.gov\/data\/inflation_calculator.htm"},{"issue":"4","key":"4615_CR64","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/OLQ.0000000000001366","volume":"48","author":"A Bingham","year":"2021","unstructured":"Bingham A, et al. Estimated lifetime HIV-Related medical costs in the United States. Sex Transm Dis. 2021;48(4):299\u2013304.","journal-title":"Sex Transm Dis"},{"key":"4615_CR65","doi-asserted-by":"publisher","first-page":"108344","DOI":"10.1016\/j.jsat.2021.108344","volume":"127","author":"TS Bartholomew","year":"2021","unstructured":"Bartholomew TS, et al. Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida. J Subst Abuse Treat. 2021;127:108344.","journal-title":"J Subst Abuse Treat"},{"key":"4615_CR66","unstructured":"National Association of County and City Health Officials. 2020 Forces of Change The COVID-19 Edition. Available from: https:\/\/www.naccho.org\/uploads\/downloadable-resources\/2020-Forces-of-Change-The-COVID-19-Edition.pdf"},{"issue":"1","key":"4615_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/jama.2015.6303","volume":"314","author":"JD Rich","year":"2015","unstructured":"Rich JD, Adashi EY. Ideological anachronism Involving needle and Syringe Exchange Programs: lessons from the Indiana HIV Outbreak. JAMA. 2015;314(1):23\u20134.","journal-title":"JAMA"},{"key":"4615_CR68","unstructured":"Legan M. Scott County to be without needle exchange program for first time in 6 years. 2021."},{"issue":"1","key":"4615_CR69","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12954-021-00575-4","volume":"18","author":"DC Des Jarlais","year":"2021","unstructured":"Des Jarlais DC, et al. Is your syringe services program cost-saving to society? A methodological case study. Harm Reduct J. 2021;18(1):126.","journal-title":"Harm Reduct J"},{"issue":"10","key":"4615_CR70","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1046\/j.1525-1497.1998.00211.x","volume":"13","author":"DK Owens","year":"1998","unstructured":"Owens DK. Interpretation of cost-effectiveness analyses. J Gen Intern Med. 1998;13(10):716\u20137.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"4615_CR71","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10461-021-03325-6","volume":"26","author":"ST Allen","year":"2022","unstructured":"Allen ST, et al. Factors Associated with Likelihood of initiating others into Injection Drug Use among people who inject drugs in West Virginia. AIDS Behav. 2022;26(1):47\u201356.","journal-title":"AIDS Behav"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04615-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04615-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04615-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T13:03:20Z","timestamp":1745672600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04615-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["4615"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04615-z","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"type":"print","value":"1090-7165"},{"type":"electronic","value":"1573-3254"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"4 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study procedures were approved by the Johns Hopkins University Bloomberg School of Public Health Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"We consent to publishing our manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"None of the authors have any conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}